Modulation of endothelial progenitor cell number and function with n-3 polyunsaturated fatty acids

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 94-97

  Devaraj, Sridevi ^a   Chien, Alexander ^b   Rao, Bhavana ^b   Chen, Xinpu ^a   Jialal, Ishwarlal ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diet; EPC; Fatty acids; Fish oils; Inflammation; N 3 PUFA

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID;

ARTICLE; CARDIOVASCULAR FUNCTION; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL;

ADULT; AGED; CELL ADHESION; CELL COUNT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENDOTHELIAL CELLS; FATTY ACIDS, OMEGA-3; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; YOUNG ADULT;

EID: 84876782364     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.036     Document Type: Article

References (16)

1. Vita J.A. Endothelial function. Circulation 2011, 124(25):e906-912.
2. Tousoulis D., Briasoulis A., Papageorgiou N., et al. Oxidative stress and endothelial function: therapeutic interventions. Recent Pat Cardiovasc Drug Discov 2011, 6(2):103-114.
3. Burger D., Touyz R.M. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 2012, (PMID: 22321962).
4. Fujita Y., Asahara T. Evaluation of circulating endothelial progenitor cells in cardiovascular risk. Circ J 2011, 75(11):2541-2542.
5. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348(7):593-600.
6. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics' exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106(22):2781-2786.
7. Fadini G.P., Avogaro A. Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes Metab 2010, 12(7):570-583.
8. Devaraj S., Jialal I. Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res 2012, (PMID:21941528).
9. Werner N., Wassmann S., Ahlers P., et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007, 102(6):565-571.
10. Jialal I., Devaraj S., Singh U., Huet B.A. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis 2010, 211(1):297-302.
11. Dasu M.R., Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors. Am J Physiol Endocrinol Metab 2011, 300:E145-E154.
12. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med 2011, 364(25):2439-2450.
13. Marchioli R., Levantesi G., Silletta M.G., et al. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Expert Rev Cardiovasc Ther 2009, 7(7):735-748.
14. Marchioli R., Schweiger C., Tavazzi L., Valagussa F. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lipids 2001, 36(Suppl):S119-S126.
15. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369(9567):1090-1098.
16. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58(20):2047-2067.